Fundz

Cytovale Inc. reported raising $7.25 Million in an initial SEC Form D filing, from an offering of $11 Million

PRIVATEDec 26, 2017

Amount Raised

$7.25 Million

$7.25 Million sold, per SEC Form D (first sale Dec 26, 2017)

Round Type

Venture

San FranciscoOtherBiotechnology

Who to call at Cytovale, and when

A new round usually means Cytovale is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cytovale raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cytovale, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cytovale

Location

150 EXECUTIVE PARK BLVD, SUITE 4100

San Francisco, California, United States

About

Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cytovale raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts14 people are listed at Cytovale. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cytovale's next move

See what Strategic adds

Cytovale raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.